Phase 2 Mesothelioma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to give written agreement to take part, and you understand you can leave the study at any time without it affecting your regular medical care
- If you are a woman, you are either past menopause for at least one year, have had a surgical procedure that means you cannot get pregnant, or you agree to use an approved form of birth control during the study and for at least 6 months after your last dose of the study drug
- If you are a man (even if you have had a vasectomy), you agree to use a condom with spermicide or to completely avoid heterosexual sex during the study and for 6 months after your last dose of the study drug
- Your blood test results show that your immune cells, platelets, and red blood cells are at acceptable levels (confirm with trial site)
- Your liver and kidney function tests are within acceptable ranges (confirm with trial site)
- You are able to carry out basic daily activities and care for yourself, even if you cannot do heavy physical work (confirm with trial site)
- You have been diagnosed with malignant mesothelioma (any location in the body and any type are acceptable)
- Your mesothelioma cannot be removed by surgery
- Your cancer cells test positive for a protein called CD30
- You may have had any amount of previous cancer treatment, or none at all
- Your cancer can be measured using medical scans, and those scans were done within the last 28 days
Who may not be able to join:
- You have had radiation treatment covering more than 25% of your bone marrow (for example, full pelvic radiation)
- You have previously had a bone marrow or organ transplant from another person
- You are currently pregnant or breastfeeding
- You have taken another experimental drug within 14 days before joining the study
- You have a serious physical or mental health condition that is likely to make it difficult to take part in the study
- You have been diagnosed with another cancer within the past 2 years (exceptions may apply for certain skin cancers or some early-stage solid tumours), or a blood cancer within the past 3 years
- You have had a serious allergic reaction to any part of the study drug, brentuximab vedotin
- You are currently in prison or likely to be incarcerated during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anne S Tsao, M.D. Anderson Cancer Center
Phone: 713-792-6363
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease control rate (DCR) defined as proportion of patients who had complete response, partial response or stable disease by Response Evaluation Criteria in Solid Tumors version 4.1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.